Risperdal and the risk of pancreatitis
Posted on Tuesday, September 16th, 2014 at 11:39 am
Although Risperdal has been approved to treat symptoms of autism, bipolar disorder, and schizophrenia, several clinical studies have suggested the drug may cause severe side-effects. In fact, a 2003 article published in Pharmacotherapy noted an increased incidence of pancreatitis among various atypical antipsychotics, including Risperdal.
Pancreatitis, or the inflammation of the pancreas, occurs when digestive enzymes are activated in the pancreas instead of the small intestine. Characteristic symptoms are abdominal pain that may radiate to the back, nausea and vomiting. Due to its many life-threatening complications, such as kidney failure, severe lung dysfunction, dehydration, and shock, pancreatitis is regarded a medical emergency that requires immediate hospitalization and monitored care.
Our dedicated team of pharmaceutical defect attorneys at Williams Kherkher have been helping Risperdal victims file claims against the drug manufacturer if they suffer from complications caused by this potentially harmful medication. To see if we can put our experience to work for you, call our offices at (888) 220-0640 today.